Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Darden Restaurants
DRI
$25.4B
| $42.1M | 0.03% |
438,274
+173,018
| +65% | +$14.6M |
|
677
PUT
Cognizant
CTSH
$26.7B
| $42.1M | 0.03% |
592,300
-61,800
| -9% | -$4.52M |
|
678
UnitedHealth
UNH
$358B
| $42M | 0.03% |
190,453
+154,153
| +425% | +$32.7M |
|
679
CALL
Procter & Gamble
PG
$335B
| $42M | 0.03% |
456,800
-112,700
| -20% | -$10.1M |
|
680
CALL
Honeywell
HON
$74.2B
| $42M | 0.03% |
302,874
+2,767
| +0.9% | +$371K |
|
681
Yelp
YELP
$1.32B
| $42M | 0.03% |
999,783
+715,034
| +251% | +$31.8M |
|
682
CALL
Eli Lilly
LLY
$1.08T
| $41.9M | 0.03% |
496,600
+270,900
| +120% | +$23M |
|
683
CALL
iShares China Large-Cap ETF
FXI
$4.16B
| $41.9M | 0.03% |
906,600
-279,800
| -24% | -$12.9M |
|
684
Commercial Metals
CMC
$7.98B
| $41.8M | 0.03% |
1,960,262
-34,422
| -2% | -$685K |
|
685
VF Corp
VFC
$5.79B
| $41.8M | 0.03% |
599,603
-1,739,328
| -74% | -$115M |
|
686
Neurocrine Biosciences
NBIX
$15.3B
| $41.7M | 0.03% |
537,407
+320,800
| +148% | +$21.9M |
|
|
MRC
687
DELISTED
MRC Global
MRC
| $41.6M | 0.03% |
2,461,580
-616,920
| -20% | -$10.2M |
|
688
PUT
Autodesk
ADSK
$54.5B
| $41.6M | 0.03% |
397,300
+148,600
| +60% | +$17.3M |
|
|
689
CALL
Palo Alto Networks
PANW
$323B
| $41.6M | 0.03% |
1,723,200
+43,800
| +3% | +$1.07M |
|
690
Yum China
YUMC
$16.2B
| $41.6M | 0.03% |
1,039,108
+458,415
| +79% | +$18.9M |
|
|
MON
691
CALL
DELISTED
Monsanto Co
MON
| $41.4M | 0.03% |
354,300
-298,700
| -46% | -$35.5M |
|
692
State Street
STT
$52.2B
| $41.3M | 0.03% |
423,260
-857,291
| -67% | -$82M |
|
|
AQUA
693
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $41.3M | 0.03% |
+1,741,264
| New | +$38.4M |
|
694
PUT
United Airlines
UAL
$41B
| $41.3M | 0.03% |
612,500
-167,900
| -22% | -$10.5M |
|
695
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$306M
| $41.2M | 0.03% |
1,219,700
+62,600
| +5% | +$2.18M |
|
696
PUT
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.5B
| $41.1M | 0.03% |
584,700
+25,200
| +5% | +$1.69M |
|
697
PUT
Medtronic
MDT
$116B
| $41M | 0.02% |
507,600
+272,000
| +115% | +$21.8M |
|
698
Hanover Insurance
THG
$7.77B
| $41M | 0.02% |
378,944
+105,700
| +39% | +$10.9M |
|
699
CALL
TJX Companies
TJX
$170B
| $40.8M | 0.02% |
1,068,400
+764,600
| +252% | +$27.7M |
|
700
Lumen
LUMN
$6.6B
| $40.8M | 0.02% |
2,445,636
+909,762
| +59% | +$15.4M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.